Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia... Show more
Expect a price pull-back in the near future.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (4.275). P/E Ratio (17.544) is within average values for comparable stocks, (74.174). RAFLF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). Dividend Yield (0.028) settles around the average of (0.025) among similar stocks. P/S Ratio (3.464) is also within normal values, averaging (9.167).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RAFLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RAFLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
Industry MedicalNursingServices
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MICHX | 10.14 | 0.11 | +1.10% |
Matthews China Small Companies Instl | |||
CMUAX | 14.03 | 0.07 | +0.50% |
Columbia Select Mid Cap Value A | |||
TRZQX | 37.08 | 0.15 | +0.41% |
T. Rowe Price Equity Income Z | |||
ARYMX | 13.32 | 0.03 | +0.23% |
American Century Global Real Estate A | |||
PASIX | 10.90 | 0.01 | +0.09% |
PACE Alternative Strategies A |
A.I.dvisor tells us that RAFLF and HLYK have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFLF and HLYK's prices will move in lockstep.
Ticker / NAME | Correlation To RAFLF | 1D Price Change % | ||
---|---|---|---|---|
RAFLF | 100% | N/A | ||
HLYK - RAFLF | 17% Poorly correlated | -5.96% | ||
ORPEF - RAFLF | 2% Poorly correlated | N/A | ||
NWKHY - RAFLF | 0% Poorly correlated | N/A | ||
KJFI - RAFLF | 0% Poorly correlated | N/A | ||
MFCSF - RAFLF | -1% Poorly correlated | +1.18% | ||
More |